
Contents
Age significantly affects the risk of developing hepatocellular carcinoma (HCC), the most common type of liver cancer, among patients with HIV and HCV who have cirrhosis.
Researchers analyzed data from 2,689 HIV/HCV patients with cirrhosis in the Veterans Affairs HIV and HCV Clinical Case Registries. Women were excluded due to low numbers and incomplete data on HCV viral load, follow-up CD4 count, or HIV viral load. Patients diagnosed with cirrhosis within 3 months of HIV diagnosis were also excluded.
Findings were presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in San Antonio.
Liver Cancer Risk Factors
| Risk Factor | Impact on Liver Cancer |
|---|---|
| Age ≥50 at HCV diagnosis | 3.73× higher risk compared to <40 |
| Age 40–50 at HCV diagnosis | 1.92× higher risk compared to <40 |
| Antipsychotic medication | 50% lower risk compared to patients not on such medication |
Over half of the study cohort was over 40 years old, Black, had a most recent CD4 count >200, and carried genotype 1 or 4 of HCV. During a median 5-year follow-up, 88 patients (3.3%) developed liver cancer.
Findings were presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in San Antonio. The study highlights the increased liver cancer risk in older patients with HCV-related cirrhosis and key factors influencing outcomes.
FAQ — Liver Cancer in Cirrhosis
A: Yes. Patients over 50 at HCV diagnosis have a significantly higher risk of developing HCC.
A: Certain antipsychotic medications were associated with about half the risk of liver cancer in this study.
A: 2,689 male HIV/HCV patients with cirrhosis; women and incomplete cases were excluded.







